Teligent is a generic pharmaceutical company. Under its own label, Co. markets and sells generic topical, branded generic and generic injectable, and generic ophthalmic pharmaceutical products in the United States and Canada. Co. also provides contract manufacturing services to the pharmaceutical, over-the-counter (OTC), and cosmetic markets. Co. develops, manufactures, fills and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as the OTC and cosmetic markets. These products are used in a range of applications from cosmetics and cosmeceuticals to the prescription treatment of conditions like dermatitis, psoriasis and eczema. The TLGT average annual return since 2015 is shown above.
The Average Annual Return on the TLGT average annual return since 2015 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether TLGT average annual return since 2015 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the TLGT average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|